Drug Safety & Recalls

Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape

Genentech announced that it will discontinue the marketing and distribution of Fuzeon® (enfuvirtide) in the U.S. by February 28, 2025....

Subscribe

Our newsletter brings you the latest news, updates, and insights directly to your inbox. Our carefully curated content is designed to keep you at the forefront of Pharmacy.

FDA Approves Expanded Use of Smallpox Vaccine for High-Risk Mpox Patients

The FDA has expanded approval for Emergent BioSolutions' smallpox vaccine, ACAM2000, to include prevention of Mpox in high-risk...

Cigna to Remove Humira from Formularies in 2025, Favoring Biosimilars

Cigna's pharmacy benefits unit, Express Scripts, plans to stop covering AbbVie's blockbuster rheumatoid arthritis drug, Humira, on some...

Texas Court Strikes Down FTC's Noncompete Ban as Overreach

A federal judge in Texas ruled that the FTC exceeded its authority in proposing a nationwide ban on noncompete agreements. The ruling...

Create your free Pyrls account!

Pyrls is a web and mobile platform that provides clinicians and professional students with curated, evidence-based information to guide proper use of medications both on the job and in training.

Pyrls.com

Rx Radio is sponsored by Pyrls.com